Hypoxia Signaling in Cancer: From Basics to Clinical PracticeAnna Sebestyén, József Tı́már|Pathology & Oncology Research|2021Cited by 109
Activity and complexes of mTOR in diffuse large B-cell lymphomas—a tissue microarray studyAnna Sebestyén, László Kopper|Modern Pathology|2012Cited by 25
Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cellsZoltán Hujber, Anna Sebestyén|Journal of Experimental & Clinical Cancer Research|2017Cited by 23
Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cellsGábor Petővári, Anna Sebestyén|Cancer Cell International|2018Cited by 19
Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma CellsGábor Petővári, Anna Sebestyén|Pathology & Oncology Research|2019Cited by 18